Breast tumour stroma is a prognostic indicator and target for therapy.
作者信息
Howell Anthony, Landberg Goran, Bergh Jonas
机构信息
Breakthrough Breast Cancer Research Unit, Paterson Institute for Cancer Research, University of Manchester, The Christie NHS Foundation Trust, University Hospital of South Manchester, Manchester M20 4BX, UK.
出版信息
Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S16. doi: 10.1186/bcr2435. Epub 2009 Dec 18.
Abstract
摘要
相似文献
1
Breast tumour stroma is a prognostic indicator and target for therapy.
Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S16. doi: 10.1186/bcr2435. Epub 2009 Dec 18.
2
Expression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysis.
Wien Klin Wochenschr. 2017 Aug;129(15-16):558-563. doi: 10.1007/s00508-017-1173-3. Epub 2017 Mar 31.
3
A genomic ruler to assess oncogenic transition between breast tumor and stroma.
PLoS One. 2018 Oct 16;13(10):e0205602. doi: 10.1371/journal.pone.0205602. eCollection 2018.
4
Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer.
J Clin Pathol. 2016 Jun;69(6):552-5. doi: 10.1136/jclinpath-2015-203493. Epub 2016 Mar 7.
5
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
Breast Cancer Res. 2011 Jul 8;13(4):213. doi: 10.1186/bcr2892.
6
Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
Br J Cancer. 2016 May 10;114(10):1117-24. doi: 10.1038/bjc.2016.104. Epub 2016 Apr 26.
7
Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.
Pathol Oncol Res. 2018 Jan;24(1):59-65. doi: 10.1007/s12253-017-0212-8. Epub 2017 Feb 24.
8
Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Mol Oncol. 2017 Oct;11(10):1399-1412. doi: 10.1002/1878-0261.12107. Epub 2017 Aug 22.
9
Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
Oncotarget. 2016 Apr 12;7(15):20773-87. doi: 10.18632/oncotarget.8014.
10
Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb.
引用本文的文献
1
Midkine as a driver of age-related changes and increase in mammary tumorigenesis.
Cancer Cell. 2024 Nov 11;42(11):1936-1954.e9. doi: 10.1016/j.ccell.2024.09.002. Epub 2024 Oct 3.
2
Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer.
Int J Mol Sci. 2021 Dec 10;22(24):13297. doi: 10.3390/ijms222413297.
3
Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy.
J Clin Med. 2020 Mar 12;9(3):776. doi: 10.3390/jcm9030776.
4
Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization.
PLoS One. 2016 Jul 7;11(7):e0157670. doi: 10.1371/journal.pone.0157670. eCollection 2016.
5
Methods of Cell Propulsion through the Local Stroma in Breast Cancer.
Int J Breast Cancer. 2014;2014:197480. doi: 10.1155/2014/197480. Epub 2014 Apr 7.
6
Endorepellin evokes autophagy in endothelial cells.
J Biol Chem. 2014 Jun 6;289(23):16114-28. doi: 10.1074/jbc.M114.556530. Epub 2014 Apr 15.
7
Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
PLoS One. 2012;7(9):e45559. doi: 10.1371/journal.pone.0045559. Epub 2012 Sep 19.
8
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.
Endocr Rev. 2012 Jun;33(3):378-455. doi: 10.1210/er.2011-1050. Epub 2012 Mar 14.
9
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.
Breast Cancer Res. 2011 Jul 8;13(4):213. doi: 10.1186/bcr2892.
10
Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.
J Mammary Gland Biol Neoplasia. 2010 Dec;15(4):389-97. doi: 10.1007/s10911-010-9195-8. Epub 2010 Dec 16.
本文引用的文献
1
Environment-mediated drug resistance: a major contributor to minimal residual disease.
Nat Rev Cancer. 2009 Sep;9(9):665-74. doi: 10.1038/nrc2714. Epub 2009 Aug 20.
2
First results for agents targeting cancer-related inflammation.
J Natl Cancer Inst. 2009 Aug 19;101(16):1110-2. doi: 10.1093/jnci/djp266. Epub 2009 Aug 11.
3
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.
Cancer Biol Ther. 2009 Jun;8(11):1071-9. doi: 10.4161/cbt.8.11.8874. Epub 2009 Jun 29.
4
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
Anticancer Res. 2009 May;29(5):1557-62.
5
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.
Mol Cancer Ther. 2009 May;8(5):1378-86. doi: 10.1158/1535-7163.MCT-08-1170. Epub 2009 May 5.
6
Stromal cell expression of caveolin-1 predicts outcome in breast cancer.
Am J Pathol. 2009 Jun;174(6):2035-43. doi: 10.2353/ajpath.2009.080924. Epub 2009 May 1.
7
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.
Am J Pathol. 2009 Jun;174(6):2023-34. doi: 10.2353/ajpath.2009.080873. Epub 2009 May 1.
8
The metastatic niche: adapting the foreign soil.
Nat Rev Cancer. 2009 Apr;9(4):285-93. doi: 10.1038/nrc2621.
9
Microenvironmental regulation of metastasis.
Nat Rev Cancer. 2009 Apr;9(4):239-52. doi: 10.1038/nrc2618. Epub 2008 Mar 12.
10
Stromal signature identifies basal breast cancers.
Nat Med. 2009 Mar;15(3):237-8; author reply 238. doi: 10.1038/nm0309-237.
Zotero 插件